Therapeutic landscape for ulcerative colitis: where is the Adacolumn^® system and where should it be?

References

• DignassAVan AsscheGLindsayJOfor the European Crohn’s and Colitis Organisation (ECCO)The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: current managementJ Crohns Colitis20104286221122489
   PubMed Web of Science ®Google Scholar
• DaneseSFiocchiCUlcerative colitisN Engl J Med20113651713172522047562
   PubMed Web of Science ®Google Scholar
• De SilvaSDevlinSPanaccioneROptimizing the safety of biologic therapy for IBDNat Rev Gastroenterol Hepatol201079310120134491
   PubMed Web of Science ®Google Scholar
• LichtensteinGRRutgeertsPSandbornWJA pooled analysis of infections, malignancy, and mortality in infliximab- and immunomodulator-treated adult patients with inflammatory bowel diseaseAm J Gastroenterol20121071051106322613901
   PubMed Web of Science ®Google Scholar
• FujimoriJYoshinoSKoiwaMImprovement in rheumatoid arthritis following application of an extracorporeal granulotrap column, G-1Rheumatol Int1996151751808717100
   PubMed Web of Science ®Google Scholar
• ShimoyamaTSawadaKTanakaTGranulocyte and monocyte apheresis with the G-1 column in the treatment of patients with active ulcerative colitisJpn I Apher199918117131
   Google Scholar
• ShimoyamaTSawadaKHiwatashiNSafety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter studyJ Clin Apher2001161911309823
   PubMed Web of Science ®Google Scholar
• HanaiHWatanabeFTakeuchiKLeukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, un-controlled, pilot studyClin Gastroenterol Hepatol20031283515017514
   PubMed Web of Science ®Google Scholar
• HanaiHWatanabeFYamadaMAdsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitisDigestion200470364415297776
   PubMed Web of Science ®Google Scholar
• NaganumaMFunakoshiSSakurabaARGranulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitisInflamm Bowel Dis20041025125715290920
   PubMed Web of Science ®Google Scholar
• YamamotoTUmegaeSKitagawaTGranulocyte and monocyte adsorptive apheresis in treatment of active distal ulcerative colitis: a prospective, pilot studyAliment Pharmacol Ther20042078379215379839
   PubMed Web of Science ®Google Scholar
• KankeKNakanoMHiraishiHTeranoAClinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitisDig Liver Dis20043681181715646427
   PubMedGoogle Scholar
• SaniabadiARHanaiHSuzukiYAdacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjuvant or an alternative to drug therapy?J Clin Apher20052017118415892107
   PubMed Web of Science ®Google Scholar
• SandbornWJPreliminary data on the use of the apheresis in inflammatory bowel diseaseInflamm Bowel Dis200612Suppl 11521
   Web of Science ®Google Scholar
• CaprilliRD’OvidioVLeukocytapheresis as promising therapy for inflammatory bowel diseaseDig Liver Dis20073943543717379590
   PubMedGoogle Scholar
• DomènechEHinojosaJEsteve-ComasGranulocytaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study (GETECCU)Aliment Pharmacol Ther2004201347135215606397
   PubMed Web of Science ®Google Scholar
• BresciGParisiGMazzoniAScatenaFCapriaATreatment of patients with acute ulcerative colitis: conventional corticosteroid therapy (MP) versus granulocytapheresis (GMA): a pilot studyDig Liver Dis20073943043417379588
   PubMedGoogle Scholar
• KruisWDignassASteinhagen-ThiessenEOpen label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid-refractory ulcerative colitisWorld J Gastroenterol2005117001700616437606
   PubMed Web of Science ®Google Scholar
• LjungTThomsenOOVatnMGranulocyte. Monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in ScandinaviaScand J Gastroenterol20074222122717327942
   PubMed Web of Science ®Google Scholar
• HabermalzBSauerlandSClinical effectiveness of selective granulocyte, monocyte adsorptive apheresis with the Adacolumn device in ulcerative colitisDig Dis Sci2010551421142819517236
   PubMed Web of Science ®Google Scholar
• NakamuraTKawagoeYMatsudaTEffect of granulocyte and monocyte adsorption apheresis on urinary albumin excretion and plasma endothelin-1 concentration in patients with active ulcerative colitisBlood Purif20042249950415528877
   PubMed Web of Science ®Google Scholar
• HanaiHIidaTTakeuchiKIntensive granulocyte and monocyte adsorption versus intravenous prednisolone in patients with severe ulcerative colitis: an unblinded randomised multi-centre controlled studyDig Liver Dis20084043344018296130
   PubMedGoogle Scholar
• MaidenLTakeuchiKBaurRSelective white cell apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapseInflamm Bowel Dis2008141413141818521900
   PubMed Web of Science ®Google Scholar
• SandsBSandbornWJFeaganBA randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitisGastroenterology200813540040918602921
   PubMed Web of Science ®Google Scholar
• TanakaTOkanobuHYoshimiSIn patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patientsDig Liver Dis20084073173618387860
   PubMedGoogle Scholar
• HanaiHIidaTTakeuchiKAdsorptive depletion of elevated proinflammatory CD14+CD16 DR monocytes in patients with inflammatory bowel diseaseAm J Gastroenterol20081031210121618177452
   PubMed Web of Science ®Google Scholar
• KashiwagiNHirataIKasukawaRA role for granulocyte and monocyte apheresis in RA treatmentTher Apher1998213414110225715
   PubMedGoogle Scholar
• MatsudaRKoideTTokoroCQuantitative cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naive ulcerative colitis during active and quiescent diseaseInflamm Bowel Dis20091532833418942752
   PubMed Web of Science ®Google Scholar
• CuadradoEAlonsoMde Juan EchanizPArenasJIRegulatory T cells in patients with inflammatory bowel diseases treated with Adacolumn granulocytapheresisWorld J Gastroenterol2008141521152718330941
   PubMed Web of Science ®Google Scholar
• WaitzGPetermannSLiebeSEmmrichJRamlowWReduction of dendritic cells by granulocyte and monocyte adsorption apheresis in patients with ulcerative colitisDig Dis Sci2008532507251518253828
   PubMed Web of Science ®Google Scholar
• HanaiHPosition of selective leukocytapheresis in the medical therapy of ulcerative colitisWorld J Gastroenterol2006477568757717171783
   PubMed Web of Science ®Google Scholar
• ShimadaMIwaseHTsuzukiTA pilot study of leukocytapheresis efficacy with 1.5 liter blood processing volume in patients with ulcerative colitisTher Apher Dial20081236837318937719
   PubMed Web of Science ®Google Scholar
• MitsuyamaKSataMTherapeutic leukocytapheresis in inflammatory bowel disease: clinical efficacy and mechanisms of actionCytotherapy20091122923719241197
   PubMed Web of Science ®Google Scholar
• HibiTAmeshimaYSekiguchiYTreating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centres in JapanDig Liver Dis20094157057719211314
   PubMedGoogle Scholar
• LjungTThomsenOOVatnMGranulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in ScandinaviaScand J Gastroenterol20074222122717327942
   PubMed Web of Science ®Google Scholar
• YamamotoTUmegaeSMatsumotoKMucosal healing in patients with ulcerative colitis during a course of selective leukocytapheresis therapy: a prospective cohort studyInflamm Bowel Dis2010161905191120310015
   PubMed Web of Science ®Google Scholar
• SakataYIwakiriRAmemoriSComparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized studyEur J Gastroenterol Hepatol20082062963318679064
   PubMed Web of Science ®Google Scholar
• SawadaKKusugamiKSuzukiYLeukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatmentAm J Gastroenterol20051001362136915929771
   PubMed Web of Science ®Google Scholar
• CabriadaJLIbargoyenNHernándezABernalACastiellaASustained remission after steroids and leukocytapheresis induced response in steroid-dependent ulcerative colitis: results at 1 yearDig Liver Dis20104243243519833566
   PubMedGoogle Scholar
• SakurabaAMotoyaSWatanabeKAn open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatmentAm J Gastroenterol20091042990299519724269
   PubMed Web of Science ®Google Scholar
• YamamotoTSatoruUMatsumotoKDaily granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis: a prospective safety and feasibility studyJ Gastroenterol2011461003100921681409
   PubMed Web of Science ®Google Scholar
• DignassAUErikssonAKilanderAPukitisARhodesJMVavrickaSClinical trial: five or ten cycles of granulocyte-monocyte apheresis show equivalent efficacy and safety in ulcerative colitisAliment Pharmacol Ther2010311286129520331579
   PubMed Web of Science ®Google Scholar
• YamamotoTSaniabadiARMaruyamaYUmegaeSMatsumotoKFactors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitisDig Liver Dis20073962663317532273
   PubMedGoogle Scholar
• D’OvidioVBresciGPrincipiBLong term efficacy of granulocyte- monocyte apheresis in ulcerative colitis: The Italian Registry of therapeutic apheresisJ Crohns Colitis20104s72
   Google Scholar
• SuzukiYYoshimuraNSaniabadiARSaitoYSelective granulocyte and monocyte apheresis as a first-line treatment for steroid naive patients with active ulcerative colitis: a prospective uncontrolled studyDig Dis Sci20044956557115185858
   PubMed Web of Science ®Google Scholar
• KimHJKimJSHanDSGranulocyte and monocyte adsorption apheresis in Korean conventional treatment-refractory patients with active ulcerative colitis: a prospective open label multicenter studyKorean J Gastroenterol200545344415665566
   PubMedGoogle Scholar
• YamamotoTUmegaeSMatsumotoKSafety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitisWorld J Gastroenterol20061252052516489663
   PubMed Web of Science ®Google Scholar
• TomomasaTKobayashiAKanekoHGranulocyte adsorptive apheresis for pediatric patients with ulcerative colitisDig Dis Sci20034875075412741466
   PubMed Web of Science ®Google Scholar
• MoriKYoshiharaTAndoTCytapheresis therapy for ulcerative colitis in three pediatric patientsJ Pediatr Gastroenterol Nutr20043954955115572898
   PubMed Web of Science ®Google Scholar
• KawasakiYSuzukiJSuzukiSSuzukiHLeukocytapheresis with leukocyte removal filter for severe ulcerative colitis in childhoodJ Pediatr Gastroenterol Nutr20043942242515448435
   PubMed Web of Science ®Google Scholar
• IkedaHIshumaruYTakayasuHEfficacy of granulocyte apheresis in pediatric patients with ulcerative colitis: a pilot studyJ Pediatr Gastroenterol Nutr20064359259617130733
   PubMed Web of Science ®Google Scholar
• Martin de CarpiJVilarPPrietoGGarcía NovoMDRibesCVareaVSafety and efficacy of granulocyte and monocyte adsorption apheresis in pediatric inflammatory bowel disease: a prospective pilot studyJ Pediatr Gastroenterol Nutr20084638639118367949
   PubMed Web of Science ®Google Scholar
• RuuskaTWeverVLindgrenFGranulocyte-monocyte adsorptive apheresis in pediatric inflammatory bowel disease: results, practical issues, safety and future perspectivesInflamm Bowel Dis2009151049105419137602
   PubMed Web of Science ®Google Scholar
• PanesJGuileraMGinardDTreatment cost of ulcerative colitis: is apheresis with Adacolumn cost-effective?Dig Liver Dis20073961762517531555
   PubMedGoogle Scholar
• PerssonUBorgSHjelmgrenEconomic evaluation of Adacolumn apheresis for treatment of patients with moderate to severe Crohn’s disease or ulcerative colitisPresented at the International Society for Pharmacoeconomics and Outcomes Research 8th Annual European CongressNovember 6–8, 2005Florence, Italy
   Google Scholar